Page values for "Insulin Degludec"

Nav

"Medicines" values

1 row is stored for this page

Field	Field type	Value
generic	`String`	Insulin degludec
brand	`String`	Tresiba
structure	`File`
classes	List of `String`, delimiter: `,`	[[:Category:Insulins\|Insulin]] • [[:Category:Ultra-long-acting_insulins\|Ultra-long-acting insulin analog]] • [[:Category:Basal_insulins\|Basal insulin]]
mechanism	`String`	'"`UNIQ--vote-00001356-QINU`"' Binds the same insulin receptor as endogenous insulin with comparable mitogenic-to-metabolic ratio'"`UNIQ--ref-00001357-QINU`"'.
uses	`String`	'"`UNIQ--vote-00001358-QINU`"', '"`UNIQ--vote-00001359-QINU`"'
starting_dose	`String`	~10 units SC at the same time daily, or 0.1-0.2 units/kg/d; titrate by fasting glucose
preparations	`String`	100 U/mL (FlexTouch pen) and 200 U/mL (FlexTouch pen, higher-dose convenience)
fda_max	`String`	Titrated to glucose; no fixed ceiling
pill_id	`Text`
routes	List of `String`, delimiter: `,`	Subcutaneous (never IV; not for use in insulin pumps)
onset	`String`	~1 hour
duration	`String`	>42 hours per dose (effectively flat once at steady state)
halflife	`String`	~25 hours apparent (functional duration well over 42 hours from multi-hexamer depot)'"`UNIQ--ref-0000135A-QINU`"'
bioavailability	`String`	~100% from subcutaneous depot
pregnancy	`String`	Insulin is the preferred glucose-lowering therapy in pregnancy; degludec has reassuring observational data.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed\|citation needed]]]</sup>
legal	`String`	[[USLegal:Prescription only\|Rx-only]] in US